株式会社極東書店トップ ＞ 商品一覧 ＞ FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics. 2nd edition
商品詳細
FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics. 2nd edition
・ISBN 978-1-4200-7354-6 hard GB£ 210.00
￥66,528.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Pisano, Douglas J. / Mantus, David S. (eds.), |
|---|---|
| 出版社 | (CRC Press Inc, US) |
| 出版年月 | 2008 |
| ページ数 | 464 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A00-51319＞ |
解説
Examines harmonization of the US Federal Food, Drug, and Cosmetic Act with international regulations as they apply to human drug and device development, research, manufacturing, and marketing. The Second Edition focuses on the new drug approval process, cGMPs, GCPs, quality system compliance, and corresponding documentation requirements. Written in a jargon-free style, it draws information from a wide range of resources. It demystifies the inner workings of the FDA and facilitates an understanding of how it operates with respect to compliance and product approval.
FDA Regulatory Affairs:
- provides a blueprint to the FDA and drug, biologic, and medical device development
- offers current, real-time information in a simple and concise format
- contains a chapter highlighting the new drug application (NDA) process
- discusses FDA inspection processes and enforcement options
- includes contributions from experts at companies such as Millennium and Genzyme, leading CRO's such as PAREXEL and the Biologics Consulting Group, and the FDA
Three all-new chapters cover:
- clinical trial exemptions
- advisory committees
- provisions for fast track